News Detail
New Delhi, 6 May 2024: Even as the central government has initiated several efforts to reduce dependence on imports of active pharmaceutical ingredients (APIs) and drug intermediates from the neighbouring country, imports of bulk drugs and intermediates from China out of the over......
View Details
Source : Pharmabiz
active pharmaceutical ingredients
APIs
drug intermediates
bulk drugs
intermediates
DGCI&S
DoP
Covid-19
APIs
production linked incentive
PLI scheme
key starting materials
active pharmaceutical ingredients
Promotion of Bulk Drug Parks
Related News
- NPPP 2012 lays down the regulatory framework for pricing of drugs (05-02-2025)
- Government Tightens Drug Quality Regulations (05-02-2025)
- UCPMP 2024 to prevent unethical marketing (05-02-2025)
- Addressing the Issue of Blood Black Marketing: The Need for Regulatory Measures (05-02-2025)
- Pharmacist arrested for deceiving female officers by impersonating an IAS officer (05-02-2025)
- Assam Rifles seized 6,900 Eskuf Cough Syrup Bottles worth Rs. 40 lakh from Nagicherra (04-02-2025)
- Illegal Call Center Busted in Sakinaka: 6 Arrested, Electronic Devices Seized (04-02-2025)
- IIT Guwahati researchers develop new trial method for personalised care (04-02-2025)
- Team will go to the companies making heavy doses of narcotic drugs, after checking the records, will ban them from supplying them (04-02-2025)
- Henkel introduces new light cure adhesives for the assembly of flexible medical devices (03-02-2025)